Summary:
The Respire study is a 12 month clinical trial on an FDA-approved drug for COPD patients.
Qualified Participants Must:
• Be 40 years of age or older
•
Be a current or former smoker
•
Be diagnosed with chronic pulmonary obstructive disorder (COPD)
•
Have a history of exacerbation requiring antibiotics or systemic steroid therapy
Qualified Participants May Receive:
Participants may receive Perforomist® Inhalation Solution or placebo, 1 year of study-related care and monitoring from a local doctor experienced in respiratory disease, and up to $800 compensation for time and travel.